Invesco Ltd.

Position in NAGE — Niagen Bioscience, Inc.

CIK 914208 Atlanta, GA

Position in NAGE

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$191,777

-$85,777 QoQ

Shares Held

43,487

-0.4% QoQ

Ownership

0.055%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 0% Shared 96% None 4%

Healthcare · as of Mar 31, 2026

Invesco Ltd. holds $10,689,611,381 across 259 Biotechnology names. NAGE ranks #220 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	5,331,554	$2,380,752,123
2	REGN	Regeneron Pharmaceuticals, Inc.	2,180,631	$1,684,842,735
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,783,394	$920,941,572
4	INSM	INSMED Inc	4,523,921	$739,751,561
5	ARGX	Argenx SE	594,697	$434,277,482
6	INCY	Incyte Corp	3,870,764	$364,316,298
7	BBIO	BridgeBio Pharma, Inc.	4,592,814	$341,062,362
8	HALO	Halozyme Therapeutics, Inc.	4,012,494	$259,327,483

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$191,777	43,487	-0.4%	Shares	Defined	2026-05-12
2025-12-31	$277,554	43,641	+28.5%	Shares	Defined	2026-02-19
2025-09-30	$316,780	33,953	-92.7%	Shares	Defined	2025-11-13
2025-06-30	$6,732,480	467,209	+27.4%	Shares	Defined	2025-08-13
2025-03-31	$2,529,884	366,650	+1112.9%	Shares	Defined	2025-05-12
2024-12-31	$160,509	30,228	-17.7%	Shares	Defined	2025-02-13
2024-09-30	$133,987	36,709	-59.1%	Shares	Defined	2024-11-12
2024-06-30	$244,932	89,719	+468.2%	Shares	Defined	2024-08-13
2022-03-31	$38,840	15,789	-2.4%	Shares	Defined	2022-05-16
2021-12-31	$60,509	16,179	-2.8%	Shares	Defined	2022-02-14
2021-09-30	$104,376	16,647	+32.6%	Shares	Defined	2021-11-15
2021-06-30	$123,772	12,553	-98.5%	Shares	Defined	2021-08-17
2021-03-31	$7,581,314	811,704	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.